Voluntary exercise prevents cisplatin-induced muscle wasting during chemotherapy in mice

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Hojman, Pernille ^a   Fjelbye, Jonas ^a   Zerahn, Bo ^b   Christensen, Jesper F ^c   Dethlefsen, Christine ^a   Lonkvist, Camilla K ^b   Brandt, Claus ^a   Gissel, Hanne ^d   Pedersen, Bente Klarlund ^a   Gehl, Julie ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; ONDANSETRON; PROTEIN KINASE B; SODIUM CHLORIDE; GLYCOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; EXERCISE; FOOD INTAKE; GENE INDUCTION; GLUCOSE TOLERANCE; GLYCOGEN ANALYSIS; GLYCOGEN MUSCLE LEVEL; INFLAMMATION; LEAN BODY WEIGHT; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; MYOSITIS; NONHUMAN; OVERALL SURVIVAL; PHYSICAL CAPACITY; PROTEIN DEGRADATION; QUALITY OF LIFE; RUNNING; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; GLUCOSE INTOLERANCE; METABOLISM; MUSCULAR ATROPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

MUS;

ANIMALS; ANOREXIA; BODY WEIGHT; CISPLATIN; FEMALE; GENE EXPRESSION; GLUCOSE INTOLERANCE; GLYCOGEN; MICE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; RUNNING; SIGNAL TRANSDUCTION;

EID: 84907483645     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109030     Document Type: Article

References (28)

1. Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, et al. (2014) Muscle dysfunction in cancer patients. Ann Oncol, 25(5):947-58.
2. Scatchard K, Forrest JL, Flubacher M, Cornes P, Williams C (2012) Chemotherapy for metastatic and recurrent cervical cancer. Cochrane Database Syst Rev 10, CD006469.
3. Reveiz L, Rueda JR, Cardona AF (2012) Chemotherapy for brain metastases from small cell lung cancer. Cochrane Database Syst Rev 6, CD007464.
4. Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ (2008) Medical treatment of advanced testicular cancer. JAMA 299:672-684.
5. Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, et al. (2008) Chemotherapy-induced muscle wasting: assocation with NF-kappabeta and cancer cachexia. Basic Applied Myology 18:139-148.
6. Fanzani A, Zanola A, Rovetta F, Rossi S, Aleo MF (2010) Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol Appl Pharmacol 250:312-321.
7. Brown JC, Winters-Stone K, Lee A, Schmitz KH (2012) Cancer, physical activity, and exercise. Compr Physiol 2:2775-2809.
8. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, et al. (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Nat Cancer Inst 104:815-840.
9. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, et al. (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62:30-67.
10. Egan B, Zierath JR (2013) Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 17:162-184.
11. Smuder AJ, Kavazis AN, Min K, Powers SK. (2011) Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle. J Appl Physiol 110:935-942.
12. van Putten M (2011) The use of hanging wire tests to monitor muscle strength and condition over time. TREAT-NMD Neuromscular Network/Wellstone Muscular Dystrophy Center, Washington, DC.
13. Gissel H (2010) Effects of varying pulse parameters on ion homeostasis, cellular integrity, and force following electroporation of rat muscle in vivo. Am J Physiol Regul Integr Comp Physiol 298:R918-R929.
14. dos Santos NA, Carvalho-Rodrigues MA, Martins NM, dos Santos AC (2012) Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol 86:1233-1250.
15. Plomgaard P, Fischer CP, Ibfelt T, Pedersen BK, van Hall G (2008) Tumor necrosis factor-alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab 93:543-549.
16. Pedersen BK (2013) Muscle as a secretory organ. Compr Physiol 3:1337-1362.
17. Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457-465.
18. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, et al. (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653-1659.
19. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, et al. (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396-4404.
20. Quist M, Rørth M, Langer S, Jones LW, Laursen JH, et al. (2012) Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer 75:203-208.
21. Samuel SR, Maiya GA, Babu AS, Vidyasagar MS (2013) Effect of exercise training on functional capacity and quality of life in head and neck cancer patients receiving chemoradiotherapy. Indian J Med Res 137:515-520.
22. Christensen JF, Andersen JL, Adamsen L, Lindegaard B, Mackey AL, et al. (2011) Progressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial. BMC Cancer 11.
23. Quist M, Langer S, Rørth M, Christensen KB, Adamsen L (2013) "EXHALE": exercise as a strategy for rehabilitation in advanced stage lung cancer patients: a randomized clinical trial comparing the effects of 12 weeks supervised exercise intervention versus usual care for advanced stage lung cancer patients. BMC Cancer 13:477.
24. Jones LW, Viglianti BL, Tashjian JA, Kothadia SM, Keir ST, et al. (2010) Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol 108:343-348.
25. Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, et al. (2012) Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol 113:263-272.
26. Hojman P, Dethlefsen C, Brandt C, Hansen J, Pedersen L, et al. (2011) Exerciseinduced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab 301:E504-E510.
27. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, et al. (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358:781-786.
28. Pignon JP, le Maitre A, Maillard E, Bourhuis J, MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4-14.